Direct determination of polydatin and its metabolite in rat excrement samples by high-performance liquid chromatography

Chemical and Pharmaceutical Bulletin

Volumn 56, Issue 11, 2008, Pages 1592-1595

  Zhang, Wenting ^a,b   Li, Qing ^a   Zhu, Ming ^b   Huang, Qinwei ^b   Jia, Ying ^a   Bi, Kaishun ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b Zhejiang Institute for Drug Control   (China)

Author keywords

Excrement sample; Gastrointestinal; Intestinal flora; Metabolite; Polydatin; Resveratrol

Indexed keywords

ACETONITRILE; DRUG METABOLITE; FORMIC ACID; POLYDATIN; RESVERATROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; FECES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE FLORA; NONHUMAN; RAT; SOLID PHASE EXTRACTION; ULTRAVIOLET SPECTROSCOPY; VALIDATION PROCESS;

ANIMALS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUGS, CHINESE HERBAL; FECES; GASTROINTESTINAL TRACT; GLUCOSIDES; INDICATORS AND REAGENTS; MASS SPECTROMETRY; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET; STILBENES;

EID: 55749115742     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.56.1592     Document Type: Article

References (20)

1. Weng J., Lu Q. J., Tian Y., Zhang M., Chin. Trad. Herb. Drugs, 37, 1008-1011 (2006).
2. Chen J. Y., Wu L. J., Teng H. L., Liu K., Chin. Trad. Herb. Drugs, 34, 970-973 (2003).
3. Ma H. Y., Zhou Q. L., Wang J. Y., China J. Chin. Mater. Med., 27, 680-683 (2002).
4. Shen L., Xu D. S., Feng Y., China J. Chin. Mater. Med., 30, 618-620 (2005).
5. Chen H. X., Du P., Han F. M., Journal of Hubei University (Natural Science), 28, 414-416 (2006).
6. Lei L., Song Z. H., Tu P. F., Acta Pharmaceutica Sinica, 36, 432-435 (2001).
7. Ju W. Z., Chu J. H., Tan R. X., Chin. J. Clin. Pharnacol. Ther., 11, 292-295 (2006).
8. Yang X. F., Song C. Q., China J. Chin. Mater. Med., 25, 673-676 (2000).
9. Chen X., Zhou Q. L., Wang B. X., Acta Pharmaceutica Sinica, 34, 410-414 (1999).
10. Qiu F., Chen Y. J., Kano Y., Acta Pharmaceutica Sinica, 34, 222-226 (1999).
11. Akao T., J. Med. Pharm. Soc., 9, 1-13 (1992).
12. Wang Y., Liu T. H., Wang W., China J. Chin. Mater. Med., 26, 188-190 (2001).
13. Pharmacopoeia Commission of the People's Republic of China, "Pharmacopoeia of the People's Republic of China (2005), Part 1," Chemical Industry Press, Beijing, 2005, pp. 145-146.
14. Xue L., China J. Chin. Mater. Med., 25, 651-653 (2000).
15. Wang L., Huang L., Zhang M., China J. Chin. Mater. Med., 27, 344-347 (2002).
16. Zhu L. X., Jin Z. Y., Tao G. J., Chin. Trad. Patent Med., 27, 944-946 (2005).
17. Zhang W. T., Jia Y., Huang Q. W., Chromatographia, 66, 685-689 (2007).
18. Zhou J. J., Zhang H. J., Yang P. J., Li H. N., Chin. Trad. Herb. Drugs, 33, 414-416 (2002).
19. Kobashi K., Akao T., Bioscience Microflora, 16, 1-3 (1997).
20. Chen H. X., Chen Y., Du P., Han F. M., Chromatographia, 65, 413-418 (2007).